|
Re: CANTOS and CIRT
|
3
|
Resverlogix Corp.
|
Nov 13, 2017 11:32PM
|
|
Re: CASH
|
4
|
Resverlogix Corp.
|
Oct 05, 2019 01:39AM
|
|
Re: CASH
|
2
|
Resverlogix Corp.
|
Oct 05, 2019 02:54PM
|
|
Re: CASH
|
1
|
Resverlogix Corp.
|
Oct 05, 2019 03:11PM
|
|
Re: CASH
|
1
|
Resverlogix Corp.
|
Oct 05, 2019 03:53PM
|
|
Re: Cash burn and the cost of servicing the loan....
|
2
|
Resverlogix Corp.
|
Apr 16, 2018 09:29PM
|
|
Re: Cash burn and the cost of servicing the loan....
|
3
|
Resverlogix Corp.
|
Apr 17, 2018 02:00AM
|
|
Re: Cash burn and the cost of servicing the loan....
|
7
|
Resverlogix Corp.
|
Apr 16, 2018 09:37AM
|
|
Re: Cash burn and the cost of servicing the loan....
|
3
|
Resverlogix Corp.
|
Apr 16, 2018 11:59AM
|
|
Re: Cash burn and the cost of servicing the loan....
|
3
|
Resverlogix Corp.
|
Apr 16, 2018 02:01PM
|
|
Re: Cash burn and the cost of servicing the loan....
|
1
|
Resverlogix Corp.
|
Apr 16, 2018 02:57PM
|
|
Re: Caution
|
4
|
Resverlogix Corp.
|
Nov 14, 2019 06:00PM
|
|
Re: Caution
|
2
|
Resverlogix Corp.
|
Nov 14, 2019 06:23PM
|
|
Re: Cayman Chemical 1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
|
|
Resverlogix Corp.
|
Jan 16, 2017 09:48AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
6
|
Zenith Epigenetics
|
Feb 03, 2019 04:01AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Jan 30, 2019 10:04AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
2
|
Zenith Epigenetics
|
Feb 11, 2019 10:41PM
|
|
Re: Checking the chart and seeing another pennant, contractions coming quicker....
|
5
|
Resverlogix Corp.
|
May 12, 2019 12:13PM
|
|
Re: Cheeseburgers and Pork Ribs
|
2
|
Resverlogix Corp.
|
Mar 09, 2017 08:15PM
|
|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
2
|
Resverlogix Corp.
|
Aug 05, 2017 02:25AM
|
